Avian Flu: How Deadly Viruses Evolve & The Role of Furin Cleavage Sites

The emergence of highly pathogenic avian influenza (HPAIV) – commonly known as bird flu – continues to be a significant concern for global public health. Recent research sheds light on a key mechanism driving the evolution of these particularly dangerous viruses: a process called polymerase trapping. Understanding this process is crucial for predicting outbreaks and developing effective countermeasures, particularly as H5 bird flu spreads across wild bird populations and, increasingly, affects poultry and even mammals like dairy cows.

The Shift from Low to High Pathogenicity

Avian influenza A viruses are categorized into subtypes based on two proteins on their surface: hemagglutinin (HA) and neuraminidase (NA). We find 18 known HA subtypes and 11 NA subtypes, with various combinations possible, such as H5N1 or H7N2. While many subtypes circulate in wild birds without causing severe illness, certain H5 and H7 strains can mutate into highly pathogenic forms. These highly pathogenic strains pose a greater threat to poultry and, occasionally, to humans. The critical step in this transformation involves acquiring a specific genetic feature: a furin-cleavable multibasic cleavage site (MBCS) within the hemagglutinin gene.

For decades, the insertion of this MBCS was identified as the primary driver of HPAIV genesis. However, the precise mechanisms governing this process remained unclear. New research, detailed in a recent study, points to “polymerase trapping” as a key factor. This means that during viral replication, the viral polymerase – an enzyme essential for copying the viral genome – gets stuck, or trapped, on the viral RNA. This trapping increases the likelihood of errors during replication, including the insertion of the MBCS.

Polymerase Trapping: How it Works

The viral polymerase is responsible for transcribing and replicating the viral RNA genome. Under normal circumstances, it moves efficiently along the RNA strand. However, certain RNA structures can impede its progress, causing it to pause or stall. The study suggests that specific RNA sequences within the avian influenza virus genome are prone to causing this trapping effect. When the polymerase is trapped, it creates opportunities for mutations to occur, including the insertion of the MBCS. This MBCS allows the virus to efficiently cleave itself within host cells, increasing its virulence and leading to the severe symptoms associated with HPAIV.

This isn’t a random process. The research indicates that the specific RNA structures that cause polymerase trapping are not evenly distributed throughout the viral genome. They are concentrated in regions where the MBCS is likely to be inserted, suggesting a targeted mechanism for the evolution of HPAIV.

Current Situation and Affected Populations

As of early March 2026, H5 bird flu is widespread in wild birds globally and is causing outbreaks in poultry. Notably, cases have similarly been detected in U.S. Dairy cows, with subsequent confirmed cases in workers who had close contact with infected animals. The Centers for Disease Control and Prevention (CDC) is closely monitoring the situation and working with state authorities to track human exposures. The CDC provides regular updates on the current situation, emphasizing that while the public health risk remains low, vigilance is essential.

The primary populations affected are poultry, with significant economic consequences for the agricultural industry. Wild aquatic birds are considered reservoirs for the virus, meaning they can carry and spread the virus without necessarily showing symptoms. Human infections are rare but can occur through direct contact with infected birds or contaminated surfaces. The recent cases in dairy workers highlight the potential for mammalian transmission, which raises concerns about the virus’s ability to adapt and spread more easily.

What Does This Mean for Risk?

It’s important to understand that the risk of human infection remains low. However, the emergence of H5 in dairy cows and the detection of cases in workers represent a change in the dynamics of the outbreak. The virus is demonstrating an ability to infect mammals, which could potentially facilitate further mutations and increase the risk of human-to-human transmission. The USDA’s Animal and Plant Health Inspection Service (APHIS) provides detailed information on avian influenza outbreaks in livestock and poultry.

The risk isn’t simply about infection; it’s about the severity of illness. HPAIV can cause severe respiratory illness and even death in humans. While antiviral medications are available, their effectiveness is highest when administered early in the course of infection.

The Role of Surveillance and Future Directions

Effective surveillance is critical for tracking the spread of avian influenza and detecting potential changes in the virus. This includes monitoring wild bird populations, poultry farms, and livestock operations. Genomic sequencing of viral isolates is essential for identifying new mutations and tracking the evolution of the virus. Research published in PMC highlights the ongoing challenges presented by emerging H5 and H7 avian influenza viruses and the necessitate for effective control strategies.

Public health authorities are continuously reviewing and updating guidance based on the latest scientific evidence. This includes recommendations for biosecurity measures on poultry farms, vaccination strategies, and antiviral treatment protocols. Further research is needed to fully understand the mechanisms driving the evolution of HPAIV and to develop more effective vaccines and antiviral drugs.

What Comes Next: Ongoing Monitoring and Research

The current focus is on continued surveillance of both animal and human populations. Researchers are working to better understand the factors that contribute to polymerase trapping and the insertion of the MBCS. This knowledge could inform the development of strategies to prevent the emergence of HPAIV. Efforts are underway to develop more broadly protective vaccines that can provide immunity against a wider range of avian influenza subtypes. Regular updates from the CDC and USDA will be crucial for staying informed about the evolving situation.